Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > lenalidomide market

Lenalidomide Market Share

Report ID: GMI8286 Published Date: February 2024Report Format: PDF
Download Free Sample
Summary
Table of Content

Lenalidomide Market Share

The competitive landscape of the lenalidomide industry is characterized by the presence of established pharmaceutical companies vying for market share. Key players are engaging in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios. The companies are actively adopting a multi-pronged approaches to address the rising demand for effective lenalidomide.

Lenalidomide Market Companies

Prominent players operating in the lenalidomide industry are as mentioned below:

  • Accord Healthcare
  • Cipla
  • Deva Pharma
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals
  • Hetero
  • Hikma Pharmaceuticals
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

Why is the demand for 10mg lenalidomide capsules increasing?+

The 10mg capsules segment generated USD 6.1 billion in revenue in 2023 and is projected to record substantial growth through 2032 as these capsules serve as a cornerstone in medical treatment regimens for offering patients a reliable and standardized dosage.

What is the size of the lenalidomide market?+

Lenalidomide industry size was worth USD 18 billion in 2023 and is set to expand at 5.1% CAGR from 2024-2032 propelled by the escalating prevalence of multiple myeloma worldwide and continuous advancements spurred by research endeavors.

How big is the North America lenalidomide industry?+

North America lenalidomide market accounted for a sizeable revenue share in 2023 and is expected to expand at a significant growth rate through 2032 owing to the heightened incidence rate of these diseases in comparison to other regions globally.

Who are the leading lenalidomide industry players?+

Some of the major lenalidomide firms are Accord Healthcare, Cipla, Deva Pharma, Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals, Hetero, Lupin Limited, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Viatris Inc., among others.

Lenalidomide Market Scope

Related Reports

Buy Now

Premium Report Details

Download Free Sample